Michael B. Hoffman - 03 Jan 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Michael Hoffman
Issuer symbol
ANVS
Transactions as of
03 Jan 2022
Net transactions value
+$10.06
Form type
4
Filing time
05 Jan 2022, 18:41:42 UTC
Previous filing
09 Jul 2021
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Options Exercise $131,700 +30,000 +2.2% $4.39 1,415,889 04 Jan 2022 Direct
transaction ANVS Common Stock Tax liability $131,695 -6,658 -0.47% $19.78 1,409,231 04 Jan 2022 Direct F1
transaction ANVS Common Stock Options Exercise $1,786 +7,142 +0.51% $0.2500* 1,416,373 04 Jan 2022 Direct
transaction ANVS Common Stock Tax liability $1,780 -90 -0.01% $19.78 1,416,283 04 Jan 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +9,000 $0.000000 9,000 03 Jan 2022 Common Stock 9,000 $19.78 Direct F3
transaction ANVS Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 04 Jan 2022 Common Stock 30,000 $4.39 Direct
transaction ANVS Stock Option (right to buy) Options Exercise $0 -7,142 -100% $0.000000* 0 04 Jan 2022 Common Stock 7,142 $0.2500 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 6,658 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $4.39 per share to fund the cashless exercise of 30,000 options.
F2 Reflects 90 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $0.25 per share to fund the cashless exercise of 7,142 options.
F3 The stock option shall vest in eight consecutive quarterly installments of 1,125 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.